A new nationwide initiative is seeking to transform the way individuals and families affected by Tuberous Sclerosis Complex connect with one another, share their lived experiences, and raise public consciousness about a rare condition that frequently leaves those diagnosed feeling isolated. The campaign, titled "TSC and Me," is designed to foster a deeply connected community by celebrating individual stories and ensuring that patients, caregivers, and supporters recognize they are never alone in their journey.
The campaign utilizes the reach of modern digital platforms to bridge geographical divides and bring together a dispersed patient population. By inviting individuals and families directly impacted by Tuberous Sclerosis Complex to share their personal narratives alongside a photograph using the designated hashtag #TSCandMe, the initiative aims to construct a powerful online mosaic. This digital gathering of voices is intended to vividly reflect the strength, diversity, and resilience that characterizes the everyday lives of those navigating the complexities of the condition.
Tuberous Sclerosis Complex is classified as a rare genetic disorder, a classification that often brings distinct challenges regarding public understanding, medical visibility, and community support. Because the condition affects individuals in vastly different ways—often involving non-cancerous tumors that can grow in the brain, kidneys, heart, lungs, eyes, and skin—the lived experience of TSC can vary dramatically from one person to another. This variability frequently contributes to a sense of isolation among patients and their families, who may not personally know others facing the same medical hurdles. The TSC and Me campaign addresses this exact challenge by providing a visible, welcoming platform where personal stories can be shared, acknowledged, and valued by a broader audience.
Participation in the campaign has been structured to be accessible to anyone wishing to contribute to the growing network of support. Individuals and families are encouraged to post their stories and photographs across social media channels using the #TSCandMe hashtag, creating an immediate ripple effect of awareness and solidarity. As these posts accumulate online, they feed directly into a centralized digital gallery known as the TSC Wall. Hosted officially on the website of the Tuberous Sclerosis Association, this dedicated space serves as a lasting, dynamic tribute to the faces and narratives of the community. Rather than existing as fleeting social media interactions, these shared contributions are preserved in a unified digital archive that documents the human reality behind the diagnosis.
The timing of the initiative is closely aligned with a broader global movement for rare disease awareness. The campaign officially runs from January 15 through February 4, culminating in a special celebration planned for Rare Disease Day 2026. This period allows the campaign to build significant momentum during a time of year when advocacy organizations worldwide focus public attention on the unique needs, challenges, and triumphs of the rare disease community. By synchronizing its schedule with Rare Disease Day, the campaign leverages international awareness efforts to bring greater visibility to Tuberous Sclerosis Complex specifically.
Organizers emphasize that the overarching value of the campaign extends far beyond digital engagement, noting that increased visibility plays a critical role in driving broader systemic changes. By making the invisible visible, the initiative demonstrates to policymakers, healthcare professionals, and the general public that behind every clinical diagnosis is a living person, a dedicated family, and a compelling story worth sharing. This heightened awareness is considered a vital stepping stone toward securing greater public and policy support, which in turn can stimulate increased research funding. Enhanced investment in scientific inquiry is essential for the development of improved therapeutic treatments and, ultimately, the pursuit of a permanent cure for Tuberous Sclerosis Complex.
